Portal Investigación UEx

PORTAL DE INVESTIGACIÓN

REVISTA

PHARMACOGENOMICS

ISSN

1462-2416

EISSN

1744-8042

JCR 2023: 1.9

Mejor cuartil: Q3

SJR 2023: 0.439

Mejor cuartil: Q3

PUBLICACIONES DE LA UEX

Pharmacogenetic And Pharmacogenomic Treatment Of Rheumatoid Arthritis: A Review Of Pharmacogenomics Knowledge Base Scientific Evidence (2024)

Pharmacogenetics: Ethnicity, Treatment And Health In Latin American Populations (2023)

The Sixth European Society Of Pharmacogenomics And Personalised Therapy Congress (2023)

Pharmacogenetics Research In Brazil: A Systematic Review (2022)

Relevance Of Nr1i2 Variants On Carbamazepine Therapy In Mexican Mestizos With Epilepsy At A Tertiary-Care Hospital (2021)

High Prevalence Of Cyp2d6 Ultrarapid Metabolizers In A Mestizo Colombian Population In Relation To Hispanic Mestizo Populations (2020)

4th Espt Conference: Pharmacogenomics And Personalized Medicine - Research Progress And Clinical Implementation (2019)

4th Espt Summer School: Precision Medicine And Personalised Health (2019)

Pharmacogenomics Education In Medical And Pharmacy Schools: Conclusions Of A Global Survey (2019)

Hypersensitivity Reactions To Nonsteroidal Anti-Inflammatory Drugs: An Update On Pharmacogenetics Studies (2018)

What Is The Future Of Pharmacogenomics In Pain Management? (2017)

Allele And Genotype Frequencies Of Genes Relevant To Anti-Epileptic Drug Therapy In Mexican-Mestizo Healthy Volunteers (2016)

Cyp450 Genotype And Pharmacogenetic Association Studies: A Critical Appraisal (2016)

Genetic Variability Of Cyp2c9∗2 And Cyp2c9∗3 In Seven Indigenous Groups From Mexico (2016)

Pharmacogenetic Research Activity In Central America And The Caribbean: A Systematic Review (2016)

Pharmacogenetics And Ethnicity: Relevance For Clinical Implementation, Clinical Trials, Pharmacovigilance And Drug Regulation In Latin America (2016)

Discussing The Putative Role Of Obesity-Associated Genes In The Etiopathogenesis Of Eating Disorders (2015)

Genetic Variants In Arachidonic Acid Pathway Genes Associated With Nsaid-Exacerbated Respiratory Disease (2015)

Interethnic Relationships Of Cyp2d6 Variants In Native And Mestizo Populations Sharing The Same Ecosystem (2015)

Pharmacogenomics Of Cyclooxygenases (2015)

Population Pharmacogenetics Of Ibero-Latinoamerican Populations (Mestifar 2014) (2015)

Cyp2d6 Gene Polymorphisms And Predicted Phenotypes In Eight Indigenous Groups From Northwestern Mexico (2014)

Cyp2d6 Genetic Polymorphisms In Southern Mexican Mayan Lacandones And Mestizos From Chiapas (2014)

Interview: Perspective On The Use Of Genomic Biomarkers In The Clinical Setting (2014)

Relationship Between The Cyp2c9 Ivs8-109a>t Polymorphism And High Losartan Hydroxylation In Healthy Ecuadorian Volunteers (2014)

Cyp2d6-1584c>g Promoter Polymorphism And Debrisoquine Ultrarapid Hydroxylation In Healthy Volunteers (2013)

Fus: A Putative Biomarker For Essential Tremor Raised By Whole-Exome Sequencing Analyses. (2013)

Genetic Biomarkers Of Essential Tremor: Time To Think Outside Of The Box. (2013)

Genome-Wide Association Study Raised Biomarker Slc1a2 Rs3794087 And Essential Tremor: Is It Too Early To Say? (2013)

Pharmacogenetics Of Clinical Response To Risperidone (2013)

Variability In Histamine Receptor Genes Hrh1, Hrh2 And Hrh4 In Patients With Hypersensitivity To Nsaids (2013)

Cyp2d6 And The Severity Of Suicide Attempts (2012)

Losartan Hydroxylation Phenotype In An Ecuadorian Population: Influence Of Cyp2c9 Genetic Polymorphism, Habits And Gender (2012)

Strengths And Weaknesses Of Pharmacogenetic Studies Of Antipsychotic Drugs: The Potential Value Of The Peps Study (2012)

Pharmacogenomics And Personalized Medicine In Clinical Practice (2011)

Cyp2w1 Variant Alleles In Caucasians And Association Of The Cyp2w1 G541a (Ala181thr) Polymorphism With Increased Colorectal Cancer Risk (2010)

Evaluating A Newly Developed Pharmacogenetic Array: Screening In A Spanish Population (2010)

Cyp2d6 Genotyping For Psychiatric Patients Treated With Risperidone: Considerations For Cost-Effectiveness Studies (2009)

Development Of A New Genotyping Assay For Detection Of The Bdnf Val66met Polymorphism Using Melting-Curve Analysis (2009)

Histamine Pharmacogenomics (2009)

Pharmacogenetics Of Debrisoquine And Its Use As A Marker For Cyp2d6 Hydroxylation Capacity (2009)

Relation Between Cyp2d6 Genotype, Personality, Neurocognition And Overall Psychopathology In Healthy Volunteers (2009)

Relevance Of Cyp2d6 -1584c>g Polymorphism For Thioridazine:mesoridazine Plasma Concentration Ratio In Psychiatric Patients (2009)

WEB ACCESIBLE

GESTIONAR COOKIES

1